Short answer: brand-name and generic FDA-approved skincare drugs (tretinoin, azelaic acid, Soolantra, Aczone, Latisse) are specific finished products reviewed by the FDA. Compounded prescriptions mix actives into custom formulas — legal when properly prescribed, but not FDA-approved as finished products.
"Pharmacy-grade" telehealth skincare often means compounded. That is not equivalent to picking up a generic tretinoin tube at CVS — even when the same molecule appears on the ingredient list.
What Brand-Name and Generic Mean Here
FDA-approved skincare drugs include defined active strength, inactive ingredients, indication, and labeling reviewed premarket.[1] After patent expiry, ANDA generics must demonstrate bioequivalence to the reference product. When you get generic tretinoin 0.05% cream, you receive a product within that regulatory framework — not a custom mix assembled ad hoc.
What Compounding Changes
Section 503A compounding allows licensed pharmacies to prepare patient-specific prescriptions combining ingredients — e.g., tretinoin + hydroquinone + kojic acid for melasma.[2] The compounded cream is not an FDA-approved drug product; the pharmacy follows compounding standards, not an NDA/ANDA review of that final blend.[4] Batch variability, stability, and combination-specific efficacy data may be less standardized than a commercial tube.
When Each Path Makes Sense
Single-ingredient FDA-approved drugs fit well-defined indications: Soolantra for rosacea lesions,[3] generic tretinoin for acne or photoaging protocols, Latisse for lash hypotrichosis. Compounding may help when clinicians want a specific strength unavailable commercially or a vetted combination — but convenience is the usual telehealth driver, not a documented FDA gap.
Critical distinction: FDA approval of an ingredient ≠ FDA approval of your compounded jar containing that ingredient.[2]
Marketing Language vs. Regulatory Status
Telehealth skincare brands often highlight dermatology imagery and "custom formulas." Strut Health, HealthRx, and Direct Meds sell compounded products — none clearly confirm board-certified dermatologist review on public pages. "Custom" describes compounding, not FDA superiority. Ask whether an FDA-approved alternative exists for your concern before defaulting to a blend.
Quality and Pharmacy Verification
Legitimate compounding pharmacies hold state licenses and follow USP standards.[4] You should be able to obtain pharmacy name and location. If a program refuses, that is a stronger red flag than choosing brand vs. compounded itself.
Bottom Line
Brand-name and generic skincare drugs offer standardized, FDA-reviewed finished products. Compounded telehealth formulas offer customization without that product-level approval. Both can be appropriate — but only if you understand which you are buying and why.
Sources
- Tretinoin Topical — MedlinePlus medlineplus.gov
- Compounding and the FDA: Questions and Answers — U.S. Food and Drug Administration fda.gov
- Soolantra (ivermectin) Cream — Prescribing Information — U.S. Food and Drug Administration accessdata.fda.gov
- Regulatory Framework for Human Drug Compounding — U.S. Food and Drug Administration fda.gov
Frequently Asked Questions
Is generic tretinoin compounded?
No — FDA-approved generic tretinoin is manufactured under ANDA standards, not mixed per individual prescription like 503A compounding.[1]
Why do telehealth brands prefer compounding?
Multi-ingredient customization and subscription branding — one jar with several actives is harder to replicate with single commercial tubes alone.[2]
Are compounded creams safer because they are personalized?
Personalization does not mean safer or more effective — it means tailored to a prescription without FDA finished-product review of that specific combination.[4]